It is intended to provide a bicyclic γ-amino acid derivative having excellent activity as an α
2
δ ligand. The present invention provides a compound represented by the general formula (I):
wherein R
1
, R
2
, R
2′
, R
4
, R
5
, R
6
, R
7
, R
8
, and R
8′
are a hydrogen atom or the like; and R
3
is a hydrogen atom, a halogen atom, a C1-C6 alkyl group, or the like.
It is intended to provide a bicyclic γ-amino acid derivative having excellent activity as an α2δ ligand. The present invention provides a compound represented by the general formula (I):
wherein R1, R2, R2′, R4, R5, R6, R7, R8, and R8′ are a hydrogen atom or the like; and R3 is a hydrogen atom, a halogen atom, a C1-C6 alkyl group, or the like.
Intermediate for producing bicyclic y-amino acid derivative
申请人:Daiichi Sankyo Company, Limited
公开号:EP2657219A1
公开(公告)日:2013-10-30
An intermediate represented by the general formula (1) is provided, useful for producing a bicyclic γ-amino acid derivative having excellent activity as an α2δ ligand:
wherein R1, R2, R2', R4, R5, R8 and R8' are each independently a hydrogen atom, and R3 is a hydrogen atom, a methyl group, an ethyl group, a propyl group, or a butyl group.
PRODRUGS OF ALPHA-2-DELTA LIGANDS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
申请人:Gallop Mark A.
公开号:US20110124705A1
公开(公告)日:2011-05-26
Prodrugs of alpha-2-delta ligands, pharmaceutical compositions of prodrugs of alpha-2-delta ligands, methods of making prodrugs of alpha-2-delta ligands, and methods of using prodrugs of alpha-2-delta ligands and pharmaceutical compositions of prodrugs of alpha-2-delta ligands to treat various diseases are disclosed.
PRODRUGS OF GAMMA-AMINO ACID, ALPHA-2-DELTA LIGANDS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
申请人:Gallop Mark A.
公开号:US20110130454A1
公开(公告)日:2011-06-02
Prodrugs of alpha-2-delta ligands, pharmaceutical compositions of prodrugs of alpha-2-delta ligands, methods of making prodrugs of alpha-2-delta ligands, and methods of using prodrugs of alpha-2-delta ligands and pharmaceutical compositions of prodrugs of alpha-2-delta ligands to treat various diseases are disclosed.